Patent analysis on Cariprazine: A novel antipsychotic agent
10.3760/cma.j.issn.1006-1924.2019.03.008
- VernacularTitle:新型抗精神病药卡利拉嗪的相关专利分析
- Author:
Naiyan SHI
1
;
Shimei WEN
Author Information
1. 上海中医药大学附属岳阳中西医结合医院 200437
- Keywords:
Schizophrenia;
Cariprazine;
Patent;
Analysis
- From:
Chinese Journal of Medical Science Research Management
2019;32(3):193-198
- CountryChina
- Language:Chinese
-
Abstract:
Objective Cariprazine is the first orally active dopamine D3-preferring D3/D2 receptor partial agonist as antipsychotic agents.It receives a lot of concern for its remarkable efficacy and broad market prospect.In this article,overall application status of cariprazine patent,which includes the patent application quantity,applicants and technical topics,as well as possible technical obstacles were statistically analyzed.Methods The patent quantitative analysis method was used,combing with pharmacy expertise,to analyze the patent application situation at home and abroad.Results The patent technology of cariprazine involves product,process,new use,component of combination,formulation and general interest.Conclusions The concern of patent situation for cariprazine was high.Patents about different salt and its crystal,analytical method and impurities should be dug up by domestic generic pharmaceutical enterprises for further generic drug development considering the existing technology barrier.
